International Journal of

Pharmaceutical Quality Assurance

e-ISSN: 0975 9506

p-ISSN: 2961-6093

Peer Review Journal

Impact Score 3.213

Disclimer: Embase, Scopus and Crossref are registered trademark of respective companies.

This journal is member of Crossref. 

Instructions to Authors
  1. The Journal will accept original and innovative submissions in English on the understanding that the work is unpublished and is not being considered for publication elsewhere.
  2. The Journal publishes reviews (comprehensive and short), original research papers and technical notes. Manuscripts will be reviewed by members of the editorial board, whose opinions will form the basis of the final decision by the editor.
  3. It is recommended that an English check of the manuscript by a competent and knowledgeable native speaker be completed before submission. Failure to follow them may result in papers being delayed or rejected.

Types of Manuscripts
Original Research papers should contain unpublished results of original research, which must be presented in sufficient detail to ensure the reproducibility of the described experiments and should present new experimental studies in elaborate form that constitute a significant contribution to knowledge.

Technical notes should contain new, important information which has not been published and for which urgent publication is desirable. An explanatory statement is required for urgent publication. In general, a technical note should not exceed 4 printed pages. Please also indicate in the cover letter the reason why the manuscript should be treated as a technical note.

Review articles are concise and critical surveys of novel accomplishments in the author’s research field and should bring up the most important current topics or present interpretative and critical accounts, but not simple compilation, on subjects of general interest. The work need not be complete; however, supporting experimental data must be described. They should be around 15 pages.

Submitting Papers to IJPQA
1. All contributions must be submitted online. In case author finds any problem with online submission then only authors can mail manuscript at  ijpqajournal@gmail.com
2. Manuscripts are accepted on the understanding that the authors have obtained the necessary authority for publication.
3. Manuscripts with multi-authors imply the consent of each of the authors.
4. The publisher will presume that the corresponding author has specifically obtained the approval of all other co-authors to submit the article to IJPQA.
5. Submission of an article to IJPQA is understood to imply that it has not been either published or not being considered for publication elsewhere.
6. Manuscripts should be neatly typed, double-spaced throughout, including tables with at least 2.5 cm margins on all sides.
7. The copyright transfer form is available here.
International Ethical Approval and Registration Requirements for Manuscripts
S.No. Manuscript Type Ethics Approval Registration / Consent
1 Original Research Required for research involving humans, patient data, samples or animals. Informed consent required where applicable.
2 Clinical Trials Mandatory IRB/IEC/REC approval before starting the trial. Prospective trial registration in WHO/ICMJE-accepted registry and informed consent required.
3 Technical Note Required only if humans, animals, samples or private patient data are involved. As applicable.
4 Meta-analysis Normally not required for published/publicly available data. Prospective protocol registration recommended. PROSPERO is not universally mandatory.
5 Systematic Review Normally not required for published/publicly available literature. Protocol registration recommended; follow PRISMA.
6 Case Series IRB/IEC/REC approval, exemption or waiver as required by local regulations. Patient consent for publication where identifiable.
7 Review Article Normally not required. No registration normally required.

Note: Authors must comply with the ethical requirements of their institution and country, together with applicable international standards such as the Declaration of Helsinki, ICMJE, WHO and PRISMA guidelines. Requirements may vary according to the study design and jurisdiction.

Manuscript Preparations
File Formats: Submit word files with tablets, photos and graphs (Colour / Black and white only) electronically embedded within the text of the document with at least 2.54 cm margins on all sides.
Manuscript Title: Top of paper, Times New Roman; Fonts all caps, bold, 14 points.
Author Names: Last name, followed by initials, corresponding author of the manuscript must be marked with an asterisk and should be list first, font: bold, 12 points.
Institution Name: Institutional address 12 points.
E-mail: Email of corresponding author, 10 points.
Numbering: Pages should be numbered consecutively; the text should be arranged in the following order: Others: Title page, Abstract, Introduction, Materials and Methods, Results, Discussion or Results and Discussion, Acknowledgements, References Figure and Tables should be appropriately included in the text.
References: The references should be listed on a separate sheet and should be numbered consecutively in the order in which they are cited in the text. Cite in the text by the appropriate arabic number e.g. 1, 2, 3 and the numbers should be superscripted.

Checklist: We have prepared few points for new authors to refer before submitting their manuscripts. It is optional to refer the following link. Checklist/Guidelines for New Authors in Scientific Community

Examples
Journals: Author (last name) AB (initials), Author BB. Title of Article. Journal name year ; volume: page numbers. Panda BB, Gaur K, Kori ML, Tyagi LK, Nema RK, Sharma CS, Jain AK. Anti-Inflammatory and analgesic activity of Jatropha gossypifolia in experimental animal models. Global Journal of Pharmacology 2009; 3(1):1-5. Books: Author AB, Author BB, Author CC. Title of Book. Ed, Vol, Publisher, City, year, page numbers. Nadkarni KM. Indian Materia Medica. Edn 3, Vol. I, Popular Prakashan, Mumbai, 2000, 242-246.

Copyright Transfer Agreement
Any article identified as containing copied or plagiarized content will be permanently removed from the journal’s website. Please note that the Article Processing Charge (APC) will not be refunded under any circumstances. Authors are fully responsible for ensuring the originality and authenticity of their submissions before publication.

Download the form and submit along with manuscript
copyright_transfer_Agreement

Download Publication Certificate
Dear Author(s) Download Publication Certificate
Certificate of Publication

Open Access/Publication Fee

Publication/Open Access Fee is USD250 per article. Authors should be aware that publication charges must be deposited only after provisional acceptance, i.e. completing peer review process including plagiarism check. In case author want to withdraw article before publication at any time, open access/publication fee will be refunded in full.

Archiving Policy

All articles are stored at different servers and DOI are provided for each article. Dr. Yashwant Research Labs Pvt. Ltd. is reponsible for backup and preservation of all content

Generative AI & AI-Assisted Technologies Policy

1. Permitted: Authors may use AI for language improvement, readability, outlining and administrative support, subject to human verification. Routine spelling and grammar checks do not require disclosure.
2. Mandatory disclosure: Disclose substantive generative-AI assistance in writing, synthesis, coding, analyses or visuals; specify tool, version (if known), purpose, affected content and human verification. Describe AI used in research methods in Methods, including validation and reproducibility.
3. Human responsibility: AI must not be named as an author. All named authors remain responsible for originality, accuracy, cited sources, patient safety, ethics approvals and the final submitted work.
4. Prohibited: Fabricated data, participants, ethics approval, citations, clinical records, results or images; undisclosed AI-written findings; and misleading manipulation of research or patient images.
5. Images: Generative alteration of evidentiary medical images, pathology images, plots and clinical photographs is prohibited. Where AI is an actual research method, report model/version, input provenance, validation and outputs; preserve originals. Non-evidentiary explanatory artwork requires editorial permission, clear labeling and rights clearance.
6. Confidentiality: Do not enter identifiable patient data, unpublished manuscripts or confidential peer-review material into public AI systems. Editors/reviewers must not upload submitted manuscripts or confidential correspondence to external generative-AI tools.
7. Enforcement: Editors may request original data, source files, prompts, logs, approvals or independent verification and may reject, correct or retract work following fair investigation. AI-detection scores alone are not proof of misconduct.
Required manuscript disclosure
“Declaration of Generative AI and AI-Assisted Technologies: [Tool name/version] was used for [specific purpose and sections]. The author(s) independently reviewed and verified the output and take full responsibility for the manuscript.”
OR
If no substantive AI was used, state: “No generative AI was used in preparing this manuscript.”
AI use in study design, screening, image interpretation, prediction, data processing or statistical analysis must additionally be documented in the Methods section with validation details.

This journal is present in UGC approved List of Journals for the purpose of Career Advancement Scheme (CAS) and Direct Recruitment of Teachers and other academic staff as required under the UGC (Minimum Qualifications for Appointment of Teachers and other Academic Staff in Universities and Colleges)